vs
Side-by-side financial comparison of AerSale Corp (ASLE) and Cytek Biosciences, Inc. (CTKB). Click either name above to swap in a different company.
AerSale Corp is the larger business by last-quarter revenue ($90.9M vs $62.1M, roughly 1.5× Cytek Biosciences, Inc.). AerSale Corp runs the higher net margin — 5.9% vs -70.9%, a 76.9% gap on every dollar of revenue. On growth, Cytek Biosciences, Inc. posted the faster year-over-year revenue change (8.1% vs -4.0%). AerSale Corp produced more free cash flow last quarter ($9.8M vs $-1.8M). Over the past eight quarters, Cytek Biosciences, Inc.'s revenue compounded faster (17.7% CAGR vs 0.2%).
AerSale, Inc. is a Doral, Florida-based global supplier of aftermarket commercial jet aircraft, engines, used materials, and aeronautical engineering services to passenger and cargo airlines, government, multinational original equipment manufacturers, and independent MROs. AerSale is a member of the Aircraft Fleet Recycling Association.
Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.
ASLE vs CTKB — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $90.9M | $62.1M |
| Net Profit | $5.4M | $-44.1M |
| Gross Margin | 34.1% | 52.9% |
| Operating Margin | 7.8% | -9.0% |
| Net Margin | 5.9% | -70.9% |
| Revenue YoY | -4.0% | 8.1% |
| Net Profit YoY | 99.7% | -557.1% |
| EPS (diluted) | $0.10 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $90.9M | $62.1M | ||
| Q3 25 | $71.2M | $52.3M | ||
| Q2 25 | $107.4M | $45.6M | ||
| Q1 25 | $65.8M | $41.5M | ||
| Q4 24 | $94.7M | $57.5M | ||
| Q3 24 | $82.7M | $51.5M | ||
| Q2 24 | $77.1M | $46.6M | ||
| Q1 24 | $90.5M | $44.9M |
| Q4 25 | $5.4M | $-44.1M | ||
| Q3 25 | $-120.0K | $-5.5M | ||
| Q2 25 | $8.6M | $-5.6M | ||
| Q1 25 | $-5.3M | $-11.4M | ||
| Q4 24 | $2.7M | $9.6M | ||
| Q3 24 | $509.0K | $941.0K | ||
| Q2 24 | $-3.6M | $-10.4M | ||
| Q1 24 | $6.3M | $-6.2M |
| Q4 25 | 34.1% | 52.9% | ||
| Q3 25 | 30.2% | 52.7% | ||
| Q2 25 | 32.9% | 52.3% | ||
| Q1 25 | 27.3% | 48.6% | ||
| Q4 24 | 31.4% | 58.5% | ||
| Q3 24 | 28.6% | 56.3% | ||
| Q2 24 | 28.2% | 54.6% | ||
| Q1 24 | 31.8% | 51.3% |
| Q4 25 | 7.8% | -9.0% | ||
| Q3 25 | 4.0% | -17.6% | ||
| Q2 25 | 11.7% | -23.3% | ||
| Q1 25 | -10.1% | -36.1% | ||
| Q4 24 | 5.2% | 5.2% | ||
| Q3 24 | 2.4% | -8.2% | ||
| Q2 24 | -2.4% | -18.3% | ||
| Q1 24 | 5.2% | -23.9% |
| Q4 25 | 5.9% | -70.9% | ||
| Q3 25 | -0.2% | -10.5% | ||
| Q2 25 | 8.0% | -12.2% | ||
| Q1 25 | -8.0% | -27.5% | ||
| Q4 24 | 2.9% | 16.8% | ||
| Q3 24 | 0.6% | 1.8% | ||
| Q2 24 | -4.7% | -22.4% | ||
| Q1 24 | 6.9% | -13.8% |
| Q4 25 | $0.10 | — | ||
| Q3 25 | $0.00 | — | ||
| Q2 25 | $0.18 | — | ||
| Q1 25 | $-0.10 | — | ||
| Q4 24 | $0.05 | — | ||
| Q3 24 | $0.01 | — | ||
| Q2 24 | $-0.07 | — | ||
| Q1 24 | $0.12 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $4.4M | $90.9M |
| Total DebtLower is stronger | $1.3M | — |
| Stockholders' EquityBook value | $424.4M | $341.7M |
| Total Assets | $640.5M | $461.5M |
| Debt / EquityLower = less leverage | 0.00× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $4.4M | $90.9M | ||
| Q3 25 | $5.3M | $93.3M | ||
| Q2 25 | $5.7M | $75.5M | ||
| Q1 25 | $4.7M | $95.3M | ||
| Q4 24 | $4.7M | $98.7M | ||
| Q3 24 | $9.8M | $162.3M | ||
| Q2 24 | $4.3M | $177.9M | ||
| Q1 24 | $2.6M | $168.8M |
| Q4 25 | $1.3M | — | ||
| Q3 25 | $1.5M | — | ||
| Q2 25 | $907.0K | — | ||
| Q1 25 | $1.1M | — | ||
| Q4 24 | $1.2M | — | ||
| Q3 24 | $376.0K | — | ||
| Q2 24 | $522.0K | — | ||
| Q1 24 | $3.5M | — |
| Q4 25 | $424.4M | $341.7M | ||
| Q3 25 | $417.1M | $378.6M | ||
| Q2 25 | $415.9M | $377.6M | ||
| Q1 25 | $406.5M | $379.6M | ||
| Q4 24 | $455.6M | $395.7M | ||
| Q3 24 | $451.5M | $385.5M | ||
| Q2 24 | $449.8M | $389.1M | ||
| Q1 24 | $452.0M | $392.6M |
| Q4 25 | $640.5M | $461.5M | ||
| Q3 25 | $646.3M | $494.9M | ||
| Q2 25 | $646.7M | $493.3M | ||
| Q1 25 | $646.1M | $482.6M | ||
| Q4 24 | $604.7M | $499.5M | ||
| Q3 24 | $601.5M | $491.2M | ||
| Q2 24 | $598.7M | $483.7M | ||
| Q1 24 | $571.7M | $492.1M |
| Q4 25 | 0.00× | — | ||
| Q3 25 | 0.00× | — | ||
| Q2 25 | 0.00× | — | ||
| Q1 25 | 0.00× | — | ||
| Q4 24 | 0.00× | — | ||
| Q3 24 | 0.00× | — | ||
| Q2 24 | 0.00× | — | ||
| Q1 24 | 0.01× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $11.4M | $-771.0K |
| Free Cash FlowOCF − Capex | $9.8M | $-1.8M |
| FCF MarginFCF / Revenue | 10.8% | -2.9% |
| Capex IntensityCapex / Revenue | 1.7% | 1.6% |
| Cash ConversionOCF / Net Profit | 2.11× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-29.1M | $-8.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $11.4M | $-771.0K | ||
| Q3 25 | $-8.9M | $-3.9M | ||
| Q2 25 | $19.8M | $108.0K | ||
| Q1 25 | $-45.2M | $-125.0K | ||
| Q4 24 | $37.5M | $2.0M | ||
| Q3 24 | $10.4M | $13.2M | ||
| Q2 24 | $-15.3M | $6.2M | ||
| Q1 24 | $-21.5M | $4.0M |
| Q4 25 | $9.8M | $-1.8M | ||
| Q3 25 | $-9.8M | $-4.6M | ||
| Q2 25 | $18.6M | $-1.5M | ||
| Q1 25 | $-47.6M | $-974.0K | ||
| Q4 24 | $32.3M | $1.1M | ||
| Q3 24 | $8.9M | $12.2M | ||
| Q2 24 | $-18.9M | $5.2M | ||
| Q1 24 | $-25.0M | $3.4M |
| Q4 25 | 10.8% | -2.9% | ||
| Q3 25 | -13.8% | -8.7% | ||
| Q2 25 | 17.3% | -3.2% | ||
| Q1 25 | -72.4% | -2.3% | ||
| Q4 24 | 34.0% | 1.9% | ||
| Q3 24 | 10.7% | 23.7% | ||
| Q2 24 | -24.6% | 11.0% | ||
| Q1 24 | -27.7% | 7.6% |
| Q4 25 | 1.7% | 1.6% | ||
| Q3 25 | 1.3% | 1.3% | ||
| Q2 25 | 1.1% | 3.5% | ||
| Q1 25 | 3.7% | 2.0% | ||
| Q4 24 | 5.6% | 1.6% | ||
| Q3 24 | 1.9% | 2.0% | ||
| Q2 24 | 4.7% | 2.3% | ||
| Q1 24 | 3.9% | 1.3% |
| Q4 25 | 2.11× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 2.31× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 13.89× | 0.21× | ||
| Q3 24 | 20.52× | 14.05× | ||
| Q2 24 | — | — | ||
| Q1 24 | -3.42× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASLE
| Products | $57.8M | 64% |
| Maintenance | $23.2M | 26% |
| Leasing Arrangements | $9.9M | 11% |
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
